BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37606559)

  • 1. A rare encounter: Kikuchi-Fujimoto disease presenting atypically after BNT162b2 COVID-19 vaccination: a case report.
    Nam KH; Choi Y
    Scand J Rheumatol; 2023 Nov; 52(6):705-707. PubMed ID: 37606559
    [No Abstract]   [Full Text] [Related]  

  • 2. Kikuchi-Fujimoto disease associated with hemophagocytic lymphohistiocytosis following the BNT162b2 mRNA COVID-19 vaccination.
    Caocci G; Fanni D; Porru M; Greco M; Nemolato S; Firinu D; Faa G; Scuteri A; La Nasa G
    Haematologica; 2022 May; 107(5):1222-1225. PubMed ID: 34965702
    [No Abstract]   [Full Text] [Related]  

  • 3. Kikuchi-Fujimoto disease can present as delayed lymphadenopathy after COVID-19 vaccination.
    Kashiwada T; Saito Y; Terasaki Y; Shirakura Y; Shinbu K; Tanaka T; Tanaka Y; Seike M; Gemma A
    Hum Vaccin Immunother; 2022 Nov; 18(5):2071080. PubMed ID: 35583472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Kikuchi-Fujimoto disease: about a case].
    Elfihri S; Laine M; Kettani F; Ben Amor J; Bourkadi JE
    Pan Afr Med J; 2017; 27():144. PubMed ID: 28904672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kikuchi-Fujimoto Disease Following COVID-19 Vaccination: Experience at a Population-Based Referral Center.
    Craig JW; Farinha P; Jiang A; Lytle A; Skinnider B; Slack GW
    Am J Clin Pathol; 2023 Aug; 160(2):114-118. PubMed ID: 37526500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kikuchi-Fujimoto disease type lymph node reaction with increased plasmacytoid dendritic cells may appear as a side effect following COVID-19 vaccination: Report of a case and literature review.
    Moreno de Juan G; Pérez Del Barrio A; Herrera Romero EG; González Ruiz M; Montes Moreno S
    Rev Esp Patol; 2024; 57(1):42-47. PubMed ID: 38246709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kikuchi disease and COVID-19 vaccination.
    Yu SC
    Am J Clin Pathol; 2024 Feb; 161(2):206-207. PubMed ID: 37824747
    [No Abstract]   [Full Text] [Related]  

  • 8. Kikuchi-Fujimoto disease following COVID-19 in a 32-year-old woman.
    Yamada R; Komohara Y; Yoshii H
    J Clin Exp Hematop; 2023 Sep; 63(3):209-211. PubMed ID: 37518269
    [No Abstract]   [Full Text] [Related]  

  • 9. Kikuchi-Fujimoto disease: a case report and the evaluation of diagnostic procedures.
    Xu S; Sun W; Liu J
    BMC Oral Health; 2019 Oct; 19(1):223. PubMed ID: 31638953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kikuchi-Fujimoto Disease and COVID-19 vaccination: pharmacovigilance approach.
    Rodríguez-Ferreras A; Maray I; Coya-Fernández C; Octavio-Bocigas MM; Fernández-Del Río MF; Casares-López S; Ruiz-Salazar J
    Eur Ann Allergy Clin Immunol; 2023 Nov; 55(6):278-282. PubMed ID: 36458479
    [No Abstract]   [Full Text] [Related]  

  • 11. Kikuchi-Fujimoto disease following SARS-CoV-2 vaccination.
    Ikeda K; Kakehi E; Adachi S; Kotani K
    BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36414349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case report: Kikuchi-Fujimoto disease].
    Ergönül O; Kocagül Celikbaş A; Altin N; Eren S; Baykam N; Dokuzoğuz B
    Mikrobiyol Bul; 2004 Oct; 38(4):455-9. PubMed ID: 15700674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Necrotizing lymphadenitis (Kikuchi-Fujimoto disease) as a rare cause of cervical lymphadenopathies. Diagnosis and differential diagnosis].
    Wüstenberg EG; Theissig F; Offergeld C; Hüttenbrink KB
    Laryngorhinootologie; 2000 Feb; 79(2):93-5. PubMed ID: 10738716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric Kikuchi-Fujimoto disease masquerading as a submandibular gland tumor.
    Chiang YC; Chen RM; Chao PZ; Yang TH; Lee FP
    Int J Pediatr Otorhinolaryngol; 2004 Jul; 68(7):971-4. PubMed ID: 15183591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reply to "Kikuchi disease and COVID-19 vaccination".
    Craig JW; Farinha P; Jiang A; Skinnider B; Slack GW; Lytle A
    Am J Clin Pathol; 2024 Feb; 161(2):208-209. PubMed ID: 37824731
    [No Abstract]   [Full Text] [Related]  

  • 16. [Kikuchi-Fujimoto's disease or histiocytic necrotizing lymphadenitis: A report of two familial cases].
    Bakir R; Lecapitaine AL; Chevalier J; Juberthie B; Bouldouyre MA; Gros H
    Rev Med Interne; 2016 Nov; 37(11):771-774. PubMed ID: 26907374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kikuchi fujimoto disease and systemic lupus erythematosus--a rare association.
    Londhey VA; Buche AS; Kini SH; Rajadhyaksha GC
    J Assoc Physicians India; 2010 Oct; 58():642-3. PubMed ID: 21510120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fever with lymphadenopathy - Kikuchi Fujimoto disease, a great masquerader: a case report.
    Dalugama C; Gawarammana IB
    J Med Case Rep; 2017 Dec; 11(1):349. PubMed ID: 29246252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kikuchi-Fujimoto Disease: part of the differential diagnosis of cervical lymphadenopathy in an HIV-positive patient.
    Thomson-Glover R; Lawton M; Menon G
    Int J STD AIDS; 2015 Jul; 26(8):602-4. PubMed ID: 25080288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Successful management of Kikuchi-Fujimoto disease caused by SARS-CoV-2].
    Iszlai Z; Török L; Tóth E; Karosi T
    Orv Hetil; 2022 Jul; 163(27):1061-1065. PubMed ID: 35895470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.